|
Re: Financials
|
1
|
Resverlogix Corp.
|
Aug 17, 2021 11:32AM
|
|
Re: Zenith Email this morning
|
5
|
Zenith Epigenetics
|
Aug 18, 2021 11:06AM
|
|
Re: Zenith Email this morning
|
3
|
Zenith Epigenetics
|
Aug 18, 2021 01:50PM
|
|
Re: Zenith Email this morning
|
3
|
Zenith Epigenetics
|
Aug 18, 2021 04:54PM
|
|
Re: To Be or Not to Be?
|
4
|
Resverlogix Corp.
|
Aug 19, 2021 10:33AM
|
|
Re: So, the mood this week was.
|
5
|
Resverlogix Corp.
|
Aug 24, 2021 10:28AM
|
|
Re: Trillium
|
5
|
Zenith Epigenetics
|
Aug 25, 2021 11:20AM
|
|
Re: So, the mood this week was.
|
3
|
Resverlogix Corp.
|
Aug 25, 2021 06:54PM
|
|
Re: So, the mood this week was.
|
5
|
Resverlogix Corp.
|
Aug 26, 2021 10:48AM
|
|
Re: Trillium
|
4
|
Zenith Epigenetics
|
Aug 26, 2021 11:11AM
|
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 26, 2021 12:27PM
|
|
Re: Trillium
|
2
|
Zenith Epigenetics
|
Aug 26, 2021 07:18PM
|
|
Re: So, the mood this week was.
|
2
|
Resverlogix Corp.
|
Aug 27, 2021 05:11PM
|
|
Re: ZEN-3694 in combination with "enzalutamide" in patients with metastatic castration resistant prostate cancer (mCRPC)
|
4
|
Zenith Epigenetics
|
Aug 27, 2021 06:18PM
|
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 28, 2021 09:59AM
|
|
Re: Video presentation from August 25, 2021
|
7
|
Resverlogix Corp.
|
Aug 31, 2021 11:22AM
|
|
Zenith Shareholders
|
2
|
Zenith Epigenetics
|
Aug 31, 2021 08:04PM
|
|
Re: Zenith Shareholders
|
1
|
Zenith Epigenetics
|
Sep 01, 2021 11:36AM
|
|
Re: Zenith Shareholders
|
1
|
Zenith Epigenetics
|
Sep 01, 2021 04:48PM
|
|
Thoughts on ZCC
|
6
|
Zenith Epigenetics
|
Sep 02, 2021 12:22PM
|
